/PRNewswire/ --Faced with increasing challenges such as costly treatments and treatments that are palliative rather than symptomatic, the global... ...http://in.advfn.com/p.php?pid=nmona&article=67898623
Singapore: Hepatitis C drug, Daklinza (daclatasvir), an NS5A replication complex inhibitor, developed by Bristol-Myers Squibb, is approved by US... ...http://www.biospectrumasia.com/biospectrum/regulatory/221993/fda-approves-bms-hep-c-drug?WT.rss_f=Pharma&WT.rss_a=FDA+approves+BMS%27+hep+C+drug
Nifty futures/Bank Nifty futures market closed on 8540/ 18680. According to technical analysis if Nifty futures and Bank Nifty future moves... ...http://pressreleaseping.com/equity-research-report-ways2capital-28-july-2015
/PRNewswire/ -- RnRMarketResearch.com adds 2015 edition octreotide market research reports providing forecasts to 2021, China octreotide... ...http://in.advfn.com/p.php?pid=nmona&article=67895455
Get trained on FDAâÂ€Â™s regulatory...
This CAPA training for medical device...